
University of Bristol spin-out Rosa Biotech, which is developing technology that mimics the sense of smell to detect chronic diseases, has raised £760,000 to commercialise its ground-breaking innovation. The firm’s artificial Intelligence (AI)-driven biosensing technology, which is capable of detecting the faint chemical signature given off by diseases, has...